Insulin resistance syndrome and nonalcoholic fatty liver disease. 2003

Anna Mae Diehl, and Jeanne Clarke, and Frederick Brancati

UI MeSH Term Description Entries
D008297 Male Males
D009749 Nutrition Surveys A systematic collection of factual data pertaining to the nutritional status of a human population within a given geographic area. Data from these surveys are used in preparing NUTRITION ASSESSMENTS. NHANES,National Health and Nutrition Examination Survey,Nutritional Surveys,Nutrition Survey,Nutritional Survey,Survey, Nutrition,Survey, Nutritional,Surveys, Nutrition,Surveys, Nutritional
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D005234 Fatty Liver Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS. Liver Steatosis,Steatohepatitis,Steatosis of Liver,Visceral Steatosis,Liver Steatoses,Liver, Fatty,Steatohepatitides,Steatoses, Liver,Steatoses, Visceral,Steatosis, Liver,Steatosis, Visceral,Visceral Steatoses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D024821 Metabolic Syndrome A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome include ABDOMINAL OBESITY; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic (THROMBOSIS) state. Cardiometabolic Syndrome,Insulin Resistance Syndrome X,Metabolic Syndrome X,Reaven Syndrome X,Dysmetabolic Syndrome X,Metabolic Cardiovascular Syndrome,Metabolic X Syndrome,Syndrome X, Insulin Resistance,Syndrome X, Metabolic,Cardiometabolic Syndromes,Cardiovascular Syndrome, Metabolic,Cardiovascular Syndromes, Metabolic,Metabolic Syndromes,Syndrome X, Dysmetabolic,Syndrome X, Reaven,Syndrome, Cardiometabolic,Syndrome, Metabolic,Syndrome, Metabolic Cardiovascular,Syndrome, Metabolic X,Syndromes, Cardiometabolic,Syndromes, Metabolic,X Syndrome, Metabolic

Related Publications

Anna Mae Diehl, and Jeanne Clarke, and Frederick Brancati
March 2005, The Journal of clinical endocrinology and metabolism,
Anna Mae Diehl, and Jeanne Clarke, and Frederick Brancati
June 2010, Current pharmaceutical design,
Anna Mae Diehl, and Jeanne Clarke, and Frederick Brancati
June 2005, Diabetes care,
Anna Mae Diehl, and Jeanne Clarke, and Frederick Brancati
November 2019, The New England journal of medicine,
Anna Mae Diehl, and Jeanne Clarke, and Frederick Brancati
May 2016, Clinics in liver disease,
Anna Mae Diehl, and Jeanne Clarke, and Frederick Brancati
December 2015, Molecular and cellular endocrinology,
Anna Mae Diehl, and Jeanne Clarke, and Frederick Brancati
June 2007, Diabetes care,
Anna Mae Diehl, and Jeanne Clarke, and Frederick Brancati
December 2023, Clinical and experimental pediatrics,
Anna Mae Diehl, and Jeanne Clarke, and Frederick Brancati
September 2017, Nature reviews. Endocrinology,
Anna Mae Diehl, and Jeanne Clarke, and Frederick Brancati
August 2019, Hepatology (Baltimore, Md.),
Copied contents to your clipboard!